CCP
IDXX icon

Cunning Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Cunning Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,015
Closed -$1.01M – 49
2020
Q4 		$1.01M Buy
+2,015
New +$902K 0.54% 33

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cunning Capital Partners's IDXX Position: Q1 2021 in Review

Cunning Capital Partners sold out of Idexx Laboratories (IDXX) in Q1 2021, closing a stake of 2,015 shares — an estimated $1.01M sold.

Cunning Capital Partners first reported a position in IDXX in Q4 2020 and held it in 1 quarter. The position peaked at $1.01M in Q4 2020. 1,011 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

  • Cunning Capital Partners reported no remaining Idexx Laboratories position as of Q1 2021 after selling out during the quarter.
  • Cunning Capital Partners sold 2,015 Idexx Laboratories shares in Q1 2021, an estimated $1.01M.
  • Cunning Capital Partners first reported a position in Idexx Laboratories in Q4 2020 and held it in 1 quarter.
  • Cunning Capital Partners's Idexx Laboratories position peaked at $1.01M in Q4 2020.
  • 1,011 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on Cunning Capital Partners's 13F filing for Q1 2021, filed 14 May 2021.